Stockreport

Why SELLAS Life Sciences Group (SLS) Is Up 12.6% After Encouraging SLS009 Phase 2 AML Data And What's Next [Yahoo! Finance]

SELLAS Life Sciences Group, Inc.  (SLS) 
Last sellas life sciences group, inc. earnings: 11/14 04:41 pm Check Earnings Report
PDF Earlier in December 2025, SELLAS Life Sciences Group reported Phase 2 data showing its investigational drug SLS009, combined with azacitidine and venetoclax, achieved a [Read more]